AnodyneWiki

Rilmazafone

Rilmazafone
Rilmazafone
Salts
[]
Rilmazafone hydrochloride
Rilmazafone hydrochloride
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass475.30 g/mol [1]
Predicted LogP2.3 [1]
Structural Identifiers
[]
Molecular formulaC21H20Cl2N6O3
IUPAC name5-[[(2-aminoacetyl)amino]methyl]-1-[4-chloro-2-(2-chlorobenzoyl)phenyl]-N,N-dimethyl-1,2,4-triazole-3-carboxamide
SMILESCN(C)C(=O)C1=NN(C(=N1)CNC(=O)CN)C2=C(C=C(C=C2)Cl)C(=O)C3=CC=CC=C3Cl
InChIInChI=1S/C21H20Cl2N6O3/c1-28(2)21(32)20-26-17(11-25-18(30)10-24)29(27-20)16-8-7-12(22)9-14(16)19(31)13-5-3-4-6-15(13)23/h3-9H,10-11,24H2,1-2H3,(H,25,30)
InChIKeyKYHFRCPLIGODFH-UHFFFAOYSA-N
CAS number99593-25-6
UNIICU3H37T766
PubChem CID5069
Pharmacokinetics[]
Elimination half-life10.5 h (M-4 metabolite)
MetabolismAminopeptidase (intestinal); hepatic
ExcretionUrine (44–68% within 24 h, primarily as M-4)
Routes of administrationOral (tablets)

Rilmazafone (also known as Rilmazafona, Rilmazafonum, S 450191, S-450191, Rilmazafonum [Latin], Rilmazafona [Spanish], Ex-a5707, Da-57446 or 5-(((2-Aminoacetyl)amino)methyl)-1-(4-chloro-2-(2-chlorobenzoyl)phenyl)-N,N-dimethyl-1H-1,2,4-triazole-3-carboxamide) is a substance of the aniline class.

Chemistry

Salts []

Rilmazafone is typically found in the form of its hydrochloride salt.

 []

Rilmazafone is achiral.

Rilmazafone matches Lipinski's rule of five.

Pharmacology

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

induction / metabolism / inhibition75
shared target10
shared target10
shared target10
shared target10
shared target10
shared target10
shared target10
shared target10
shared target10
shared target10
shared target10
shared target10
shared target10
shared target10
shared target10
shared target10
metabolism1

Subjective effects []

magnus / Rilmazafone []
Routes:
  • Oral
nervewing / Rilmazafone []

 []

  • Other: Rilmazafone is a Rx-only (<small>JP</small>).

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 5069, Rilmazafone. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5069
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Rilmazafone. UNII: CU3H37T766. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/CU3H37T766

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 11:18:56
drugspromissing (no DrugsPRO reagent data)2026-11-20 11:18:52
erowidmissing (no Erowid substance of that name)2026-11-20 11:18:52
gsrsok2026-11-20 11:18:53
hmdbmissing (hmdb.ca refused automated access to HMDB0257231)2026-11-20 11:18:52
keggok2026-11-20 11:18:54
pubchemok2026-11-20 11:18:52
redditmissing (no r/tripreports posts mention it)2026-11-20 11:18:52
sidermissing (not in SIDER)2026-11-20 11:18:52
structureok2026-11-20 11:18:52
wikipediaok2026-11-20 11:18:52